Neuropsychopharmacology: Are we ready for a paradigm shift?

Roger E. Meyer

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


The 'paradigm shift' in the title of this article refers to molecular biology. The real challenge to molecular biologists interested in applying their methods to an understanding of psychiatric disorders involves the development of models that account for gene/environment/development interaction. Because of the existence of homologous animal models of additive disorders, as well as a rich body of clinical observations and clinical and behavioral research, and recent data suggesting that chronic exposure to addictive drugs results in changes in gene expression in neurons from behaviorally relevant brain regions, additive disorders offer a serendipitous model (to molecular biologists) that may have relevance to subsequent application in other areas of psychiatry and psychology.

Original languageEnglish (US)
Pages (from-to)169-179
Number of pages11
Issue number3
StatePublished - Mar 1996

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Psychiatry and Mental health


Dive into the research topics of 'Neuropsychopharmacology: Are we ready for a paradigm shift?'. Together they form a unique fingerprint.

Cite this